SC 13D/A

Beneficial Ownership Report

Chemomab Therapeutics Ltd. Filed 2023-11-15 Acc 0000947871-23-001083

Documents 1

SC 13D/A Beneficial Ownership Report , ss2718111_sc13da.htm

Around this filing

2024-03-11 SC 13D/A Beneficial Ownership Report
2023-11-15 SC 13D/A Beneficial Ownership Report
2023-11-09 6-K Report of Foreign Issuer
2023-01-05 SC 13D/A Beneficial Ownership Report

Link to a passage

External

SEC EDGAR (opens in new tab)